| Literature DB >> 35285724 |
Maddison V Melchionna1, Jessica M Gullett1, Emmanuelle Bouveret2, Him K Shrestha3,4, Paul E Abraham3, Robert L Hettich3, Gladys Alexandre1.
Abstract
Membrane potential homeostasis is essential for cell survival. Defects in membrane potential lead to pleiotropic phenotypes, consistent with the central role of membrane energetics in cell physiology. Homologs of the progestin and AdipoQ receptors (PAQRs) are conserved in multiple phyla of Bacteria and Eukarya. In eukaryotes, PAQRs are proposed to modulate membrane fluidity and fatty acid (FA) metabolism. The role of bacterial homologs has not been elucidated. Here, we use Escherichia coli and Bacillus subtilis to show that bacterial PAQR homologs, which we name "TrhA," have a role in membrane energetics homeostasis. Using transcriptional fusions, we show that E. coli TrhA (encoded by yqfA) is part of the unsaturated fatty acid biosynthesis regulon. Fatty acid analyses and physiological assays show that a lack of TrhA in both E. coli and B. subtilis (encoded by yplQ) provokes subtle but consistent changes in membrane fatty acid profiles that do not translate to control of membrane fluidity. Instead, membrane proteomics in E. coli suggested a disrupted energy metabolism and dysregulated membrane energetics in the mutant, though it grew similarly to its parent. These changes translated into a disturbed membrane potential in the mutant relative to its parent under various growth conditions. Similar dysregulation of membrane energetics was observed in a different E. coli strain and in the distantly related B. subtilis. Together, our findings are consistent with a role for TrhA in membrane energetics homeostasis, through a mechanism that remains to be elucidated. IMPORTANCE Eukaryotic homologs of the progestin and AdipoQ receptor family (PAQR) have been shown to regulate membrane fluidity by affecting, through unknown mechanisms, unsaturated fatty acid (FA) metabolism. The bacterial homologs studied here mediate small and consistent changes in unsaturated FA metabolism that do not seem to impact membrane fluidity but, rather, alter membrane energetics homeostasis. Together, the findings here suggest that bacterial and eukaryotic PAQRs share functions in maintaining membrane homeostasis (fluidity in eukaryotes and energetics for bacteria with TrhA homologs).Entities:
Keywords: PAQRs; bacteria; fatty acid biosynthesis; membrane energetics; membrane potential
Mesh:
Substances:
Year: 2022 PMID: 35285724 PMCID: PMC9017321 DOI: 10.1128/jb.00583-21
Source DB: PubMed Journal: J Bacteriol ISSN: 0021-9193 Impact factor: 3.476
FIG 1The gene coding for TrhA in E. coli is coregulated with genes of unsaturated fatty acid synthesis. (A) Sequence of the trhAEC promoter. The transcription start site corresponds to the one identified in reference 38. The FabR box was identified in reference 36. The mutations introduced in the FabR box are indicated below the sequence. (B) Strains ΔfadR and ΔfadRΔfabR were transformed by the plasmids containing the indicated transcriptional fusions. Relative fluorescence intensities were measured after overnight growth at 30°C in LB supplemented with kanamycin (see Materials and Methods). (C) Strains ΔfadR and ΔfadRΔfabR were transformed by the plasmids containing the indicated transcriptional fusions. Relative fluorescence intensities were measured after overnight growth at 30°C in M9 minimal medium with 0.2% glucose or 0.2% oleate as the carbon source. (D) Strains ΔfadR and ΔfadRΔfabR were transformed by the pUA-trhA-TAP plasmid. Cultures were performed at 37°C in M9 minimal medium with 0.2% glucose or 0.2% oleate as the carbon source. Total lysates were then analyzed by Western blotting using anti-TAP antibodies.
FIG 2Control of membrane fluidity is not the primary role of TrhAEC. (A) Total fatty acid composition of E. coli WT and the ΔtrhAEC strain grown at 37°C. (B) Total fatty acid composition of E. coli WT and the ΔtrhAEC strain grown at 16°C. Error bars represent the standard deviation of two biological and two technical replicates. P values are listed above each set of bars. (C) Phospholipid headgroup analysis of E. coli WT and the ΔtrhAEC strain. The percent compositions of phosphatidylethanolamine (PE) lipids, diphosphatidylglycerol (PG) lipids, and diphosphatidylglycerol (DPG)/cardiolipin lipids are the averages from three biological replicates. (D) Membrane fluidity of E. coli WT and the ΔtrhAEC mutant. The membrane fluidity of whole cells was measured using DPH anisotropy, where greater values in anisotropy indicate a more rigid membrane. The data represent six biological replicates, where each point is the average of three technical replicates. Error bars represent the standard deviation.
FIG 3Membrane proteome of the ΔtrhAEC mutant reveals large changes in protein abundance, cellular physiology, and metabolism. (A) Venn diagram representing numbers of the differentially abundant proteins in the membrane proteome of ΔtrhAEC relative to E. coli WT. (B) Heat map of proteins that are found in decreased or increased abundance at both 37°C and 16°C in the membrane proteome of ΔtrhAEC relative to E. coli WT. The average log2 fold change of six biological replicates is represented. (C and D) Representation of proteins that are found in decreased abundance in the membrane proteome of ΔtrhAEC relative to WT E. coli at (C) 37°C and (D) 16°C. Proteins are functionally classified into GO-terms. (E and F) Representation of proteins that are found in increased abundance in the membrane proteome of ΔtrhAEC relative to WT E. coli at (E) 37°C and (F) 16°C.
FIG 4Physiology of the ΔtrhAC mutant supports defective membrane energetics. (A) E. coli WT and ΔtrhAEC mutant cells were plated on the center of a soft agar (0.3%) plate. The plates were imaged after 18 h of incubation at 28°C. (B) The total ATP production of stationary-phase E. coli WT and ΔtrhAEC mutant cells was measured as luminescence relative light units (RLU). Data represent the ATP content from three biological replicates with three technical replicates. Error bars represent the standard deviation. (C) MICs of E. coli WT and the ΔtrhAEC strain for different antibiotics. MIC values represent the average concentration of antibiotic (in μM) that observably inhibited the growth of three to five biological replicates with three technical replicates each. (D) Biofilm production of E. coli WT and the ΔtrhAEC mutant. Cultures were grown overnight in 12-well plates containing a sterile microscope slide. Biofilms that adhered to the air-liquid interface of a coverslip were stained with crystal violet and quantified at OD590. The OD590 was normalized to cell growth as OD600. Points represent quantifications of biofilm produced from three biological replicates with three technical replicates. Error bars represent the standard deviation.
FIG 5Cells lacking TrhAEC have a depolarized membrane. (A and B) The membrane potential of E. coli WT and the ΔtrhAEC strain was measured using (A) ThT and (B) DiOC2(3) fluorescent reporters. DMSO treatments represent the resting membrane potential of cells. The membrane potential of each strain was collapsed when treated with CCCP, as indicated by decreased reporter fluorescence. The data represent fluorescence from three biological replicates with three technical replicates. Error bars represent the standard deviation.
FIG 6Functional complementation of the ΔtrhAEC strain by expressing WT trhAEC using the pRH005 plasmid. (A) Membrane potentials of E. coli WT (pRH005), ΔtrhAEC (pRH005), and ΔtrhAEC (pRH005) were measured using ThT. Data represent fluorescence from five biological replicates with three technical replicates. Error bars represent the standard deviation. a, significantly different from E. coli WT (pRH005) DMSO (P < 0.05); b, significantly different from ΔtrhAEC (pRH005) DMSO (P < 0.05); c, significantly different from ΔtrhAEC (pRH005 trhAEC) DMSO (P < 0.05). (B) E. coli WT (pRH005), ΔtrhAEC (pRH005), and ΔtrhAEC (pRH005 trhAEC) cells were plated on the center of a soft agar (0.3%) plate. Plates were imaged after 18 h of incubation at 28°C.
FIG 7The ΔtrhAEC mutant is preadapted to external stressors that perturb charge or ion gradients across the membrane. (A to E) E. coli WT and the ΔtrhAEC mutant cells were grown to the logarithmic phase at 37°C in LB medium at pH 7.0 and then shifted to (A) acid stress at pH 4.5, (B) alkaline stress at pH 9.0, (C) NaCl stress at 0.75 M or 1 M NaCl, (D) KCl stress at 0.5 M or 0.75 M KCl, or (E) sorbitol stress at 1 M or 1.5 M sorbitol. All growth curves are representative of the average and standard deviation of three biological replicates with three technical replicates. (F and G) The membrane potential of E. coli WT and the ΔtrhAEC mutant was measured using (F) ThT during acid stress at pH 4.5 or (G) alkaline stress at pH 9.0. All measurements represent the membrane potential measurements from three biological and three technical replicates. Error bars represent the standard deviation. a, significantly different from E. coli WT control (P < 0.05); b, significantly different from ΔtrhAEC control (P < 0.05); c, significantly different from E. coli WT stress treatment (pH 4.5 or pH 9.0) (P < 0.05).
FIG 8The TrhA homolog in Bacillus subtilis affects membrane potential. (A) Membrane potential measurements of B. subtilis WT and the ΔtrhABS strain using ThT reporter. DMSO treatments represent the resting membrane potential of cells. The membrane potential of each strain was collapsed when treated with CCCP, as indicated by a decrease in fluorescence of ThT relative to that of the DMSO control. Data are representative of a single experiment, with one biological replicate and three technical replicates. (B) Membrane potential measurements of B. subtilis WT and the ΔtrhABS mutant using DiSC3(5) reporter. Fluorescence of the polar, hydrophobic DiSC3(5) dye is quenched as it enters polarized cells. Because CCCP is incompatible for use with DiSC3(5) in this assay (58), we used gramicidin D to depolarize Δψ. Upon membrane depolarization using gramicidin, DiSC3(5) is released back into the free medium, and fluorescence is dequenched. The data are representative of a single experiment, with one biological replicate and three technical replicates. (C) Total fatty acid composition of B. subtilis WT and the ΔtrhABS strain grown at 37°C. (D) Total fatty acid composition of B. subtilis WT and the ΔtrhABS strain grown at 16°C. Error bars represent the standard deviation of two biological and two technical replicates. P values are listed above each set of bars. (E) Membrane fluidities of B. subtilis WT and the ΔtrhABS strain grown at 37°C and 16°C. Membrane fluidity of whole cells was measured using DPH anisotropy, where higher values in anisotropy indicate a more rigid membrane. Data represent six biological replicates, where each point is the average of three technical replicates. Error bars represent the standard deviation.
List of bacterial strains, plasmids, and primers used in this study
| Strain, plasmid, or primer | Relevant properties | Reference or source |
|---|---|---|
| Strains | ||
| |
| |
| Δ | This work | |
| Δ |
| |
| Δ | P1 transduction of Δ | This work |
| MG1655 (pRH005) | MG1655 containing empty (pRH005) (Km, Cm) | This work |
| Δ | Δ | This work |
| Δ | Δ | This work |
| MG1655 (pBAD33) | MG1655 containing empty (pBAD33) (Cm) | This work |
| Δ | Δ | This work |
| Δ | Δ | This work |
| MG1655 (pTrc99a) | MG1655 containing empty (pTrc99a) (Ap) | This work |
| Δ | Δ | This work |
| Δ | Δ | This work |
| | General cloning strain | Invitrogen |
| | F-, λ-, |
|
| UB1005 Δ | F-, λ-, | This work |
| |
| |
| Δ | ||
| Plasmids | ||
| pUA66 | ori sc101, GFPmut2 (Km) |
|
| pUA- |
| |
| pUA- |
| |
| pUA- |
| |
| pUA- | Site-directed PCR mutagenesis in the FabR binding site on the pUA- | This work |
| pJL72 | TAP tag sequence |
|
| pUA-TAP | TAP tag sequence from pJL72 (BamHI/EcoRV) in pUA66 (BamHI/HincII) | This work |
| pUA-TrhAEC-TAP | This work | |
| pDONR221 | Gateway-based cloning vector (Km) | Invitrogen |
| pRH005 | Gateway-based destination vector expressing proteins fused with YFP at the C terminus; ori RK2 |
|
| pRH005 | pRH005 containing WT | This work |
| pTrc99a | Expression vector with inducible LacI promoter; ori ColE1/pMB1/pBR322, (Ap) |
|
| pTrc99a | pTrc99a containing | This work |
| pBAD33 | Expression vector with arabinose-inducible promoter; ori pACYC184/p15A (Cm) |
|
| pBAD33 | pBAD33 containing | This work |
| Primers | ||
| |
| |
| |
| |
| UP |
| |
| |
| |
| |
| |
| |
| |
| GW |
| |
| GW |
| |
| GW |
| |
| GW |
| |
| pRH005 |
| |
| pRH005 |
| |
| |
| |
| |
| |
Km, kanamycin; Cm, chloramphenicol; Ap, ampicillin; Erm, erythromycin; BGSC, Bacillus Genetic Stock Center. The restriction enzymes used are underlined as part of the primer name, and the location of these restriction sites within the primer is underlined.